Acer Therapeutics (ACER) Institutional Ownership → Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning (From American Hartford Gold Group) (Ad) Free ACER Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial Media Institutional Ownership Changes (13F Filings) for Acer Therapeutics (NASDAQ:ACER)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$37.86KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$28.90K Get ACER Insider Trade Alerts Want to know when executives and insiders are buying or selling Acer Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACER Institutional Buying and Selling by Quarter Ad American Hartford Gold GroupRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE Acer Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/3/2023 Hunter Associates Investment Management LLC60,000$55K0.0%+215.8%0.256% 5/19/2023Anson Funds Management LP129,795$98K0.0%-22.7%0.554% 2/15/2023Nantahala Capital Management LLC1,226,191$3.08M0.2%+76.0%7.693% 2/13/2023Knott David M Jr140,000$351K0.1%N/A0.878% 2/10/2023SVB Wealth LLC11,500$29K0.0%N/A0.072% 11/10/2022Nantahala Capital Management LLC696,538$968K0.1%-6.0%4.369% Get the Latest News and Ratings for ACER and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acer Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Nantahala Capital Management LLC741,010$934K0.0%-4.7%4.840% 8/5/2022 Copperwynd Financial LLC23,255$29K0.0%N/A0.152% 8/16/2021State Street Corp24,965$71K0.0%N/A0.174% 8/13/2021Northern Trust Corp19,672$57K0.0%-17.9%0.137% 8/13/2021Geode Capital Management LLC57,609$164K0.0%+38.8%0.403% 8/13/2021Vanguard Group Inc.179,143$512K0.0%+6.6%1.252% 8/12/2021XTX Topco Ltd18,770$54K0.0%N/A0.131% 8/12/2021Dimensional Fund Advisors LP14,665$42K0.0%-31.1%0.102% 5/19/2021Virtu Financial LLC17,646$55K0.0%N/A0.123% 5/19/2021Squarepoint Ops LLC75,014$233K0.0%N/A0.524% 5/14/2021Nantahala Capital Management LLC934,755$2.91M0.1%-5.6%6.532% 5/14/2021Dimensional Fund Advisors LP21,293$66K0.0%N/A0.149% 2/12/2021Federated Hermes Inc.114,091$299K0.0%-3.0%0.929% 2/10/2021HighPoint Advisor Group LLC29,205$113K0.0%N/A0.238% 11/16/2020Worth Venture Partners LLC250,518$722K0.6%+57.8%2.039% 11/12/2020Federated Hermes Inc.117,673$339K0.0%-19.5%0.988% 11/10/2020State Street Corp12,849$37K0.0%-25.6%0.108% 11/6/2020BlackRock Inc.93,638$270K0.0%-43.9%0.786% 11/6/2020 GSA Capital Partners LLP82,421$237K0.0%N/A0.692% 9/10/2020Two Sigma Securities LLC16,984$58K0.0%N/A0.143% 8/17/2020Jane Street Group LLC18,574$64K0.0%N/A0.181% 8/14/2020Worth Venture Partners LLC158,787$544K0.3%N/A1.549% 8/13/2020Federated Hermes Inc.146,097$501K0.0%+62.7%1.425% 8/12/2020Goldman Sachs Group Inc.40,312$138K0.0%-16.1%0.393% 8/12/2020 Bank of New York Mellon Corp13,726$47K0.0%-36.1%0.134% 6/19/2020State Street Corp136,735$272K0.0%+22.5%1.334% 5/13/2020Parametric Portfolio Associates LLC71,196$142K0.0%-26.8%0.705% 5/13/2020Federated Hermes Inc.89,770$179K0.0%+39.0%0.889% 5/11/2020State Street Corp136,735$272K0.0%+22.5%1.354% 5/11/2020WINTON GROUP Ltd16,195$32K0.0%-33.8%0.160% 5/6/2020 Bank of New York Mellon Corp21,479$43K0.0%+99.7%0.213% 2/14/2020UBS Group AG9,180$37K0.0%+139.7%0.091% (Data available from 1/1/2016 forward) ACER Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACER shares? During the previous two years, the following institutional investors and hedge funds held shares of Acer Therapeutics shares: Nantahala Capital Management LLC ($3.08M), Knott David M Jr ($351K), Anson Funds Management LP ($98K), Hunter Associates Investment Management LLC ($55K), and SVB Wealth LLC ($29K), Copperwynd Financial LLC ($29K).Learn more on ACER's institutional investors. Which institutional investors have been buying Acer Therapeutics stock? The following institutional investors have purchased Acer Therapeutics stock in the last 24 months: Nantahala Capital Management LLC ($529.65K), Knott David M Jr ($140K), Hunter Associates Investment Management LLC ($41K), Copperwynd Financial LLC ($23.26K), and SVB Wealth LLC ($11.50K). How much institutional buying is happening at Acer Therapeutics? Institutional investors have bought a total of 745,408 shares in the last 24 months. This purchase volume represents approximately $1.78M in transactions. Which Acer Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Acer Therapeutics stock in the last 24 months: Nantahala Capital Management LLC ($81.28K), and Anson Funds Management LP ($38.10K). How much institutional selling is happening at Acer Therapeutics? Institutional investors have sold a total of 119,382 shares in the last 24 months. This volume of shares sold represents approximately $137.10K in transactions. Related Companies: Tonix Pharmaceuticals Major Shareholders Vaxxinity Major Shareholders Aytu BioPharma Major Shareholders VBI Vaccines Major Shareholders Minerva Neurosciences Major Shareholders Vincerx Pharma Major Shareholders Indaptus Therapeutics Major Shareholders NeuroSense Therapeutics Major Shareholders Edesa Biotech Major Shareholders FSD Pharma Major Shareholders This page (NASDAQ:ACER) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acer Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.